Enhanced expression of interleukin-6 in bone and serum of metastatic renal cell carcinoma
- 1 April 1998
- journal article
- case report
- Published by Elsevier in Human Pathology
- Vol. 29 (4) , 421-424
- https://doi.org/10.1016/s0046-8177(98)90128-9
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- The Role of Interleukin-6 in the Induction of Hypercalcemia in Renal Cell Carcinoma Transplanted into Nude MiceEndocrinology, 1997
- Interferon alfa-2a plus tretinoin in patients with metastatic renal cell carcinoma: A pilot studyAmerican Journal of Health-System Pharmacy, 1997
- Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro.Journal of Clinical Investigation, 1996
- Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple MyelomaNew England Journal of Medicine, 1996
- Myeloma cells upregulate interleukin-6 secretion in osteoblastic cells through cell-to-cell contact but downregulate osteocalcinBlood, 1995
- Interleukin-6 in Renal Cell CarcinomaJournal of Urology, 1992
- Purification and Characterization of Soluble Human IL-6 Receptor Expressed in CHO CellsThe Journal of Biochemistry, 1990
- Production of cytokines by bone marrow cells obtained from patients with multiple myelomaBlood, 1989
- Interleukin‐6 (IL‐6) functions as an in vitro autocrine growth factor in renal cell carcinomasFEBS Letters, 1989
- The biology of interleukin-6Blood, 1989